Darnitsa started cooperating with the Ukrainian Pharmaceutical Student’ Association (UPSA)16 August 2022
Pharmaceutical Firm Darnitsa continues to work with young talents and announces the beginning of cooperation with the Ukrainian Pharmaceutical Students' Association (UPSA).
In July, as part of the UPSA-Kyiv "PRO Clinical" educational project for students, Darnitsa specialists held a webinar dedicated to clinical studies. The experts told about the life cycle of the medicinal product, the phases and modern standards for clinical studies, and talked with the students finishing the report.
Almost 120 students joined in viewing the lecture. The representatives of the association noted that the aid of Darnitsa experts they managed to set a new record for the number of participants at the UPSA online event.
It is worth reminding that Darnitsa also cooperates with Stud-Point Company. In July, another lecture for students was held by an Darnitsa expert as part of the "Marketing&PR School" online intensive. During the webinar “Strategic marketing: creating a marketing plan, building a brand strategy on different development cycles”, students learned about the brand development cycle and got acquainted with practical techniques for creating a brand plan. About 50 students joined the lecture. Young people willingly discussed, asked clarifying questions, and were actively interested in the topic.
Since September, Darnitsa is starting an internship program for 4–5-year students, who have the opportunity to get the appointment of junior chemist (trainee) with further development to the chemist position. Follow current vacancies on the company’s website.
“It is important for us to communicate with young talents, the next generation of specialists who will soon enter the professional market. Darnitsa is always happy to welcome new specialists and is sure that this is a great place for those who dream of making a significant contribution to the development of domestic pharmaceuticals,” Vasyl Hubarets says, the Director of corporate communications of Pharmaceutical Firm Darnitsa.
PJSC Pharmaceutical Company Darnitsa was founded in 1930. Since 1998, Darnitsa has been the leader in Ukraine as for drug production in physical terms. Strategic areas of products portfolio development include cardiology, neurology, and pain management. During the war, Darnitsa has passed 1.5 million packages of medicines at a cost of UAH 132 million for charitable uses to MOH, Ukrainian Armed Forces, hospitals and charity organisations.